Willis Towers Watson beats Q2 earnings expectations on strong organic growth

Published 31/07/2025, 12:40
 Willis Towers Watson beats Q2 earnings expectations on strong organic growth

LONDON - On Thursday, Willis Towers Watson (NASDAQ:WTW) reported second quarter adjusted earnings of $2.86 per share, exceeding analyst expectations of $2.63, while revenue of $2.3 billion topped the consensus estimate of $2.23 billion. The company delivered 5% organic revenue growth despite reported revenue remaining flat YoY due to the sale of its TRANZACT business.

The company’s shares dipped slightly by 0.14% in pre-market trading following the results.

The global advisory and broking firm saw its adjusted operating margin expand by 150 basis points to 18.5% compared to the same period last year. Adjusted EBITDA increased 6% to $470 million, representing 20.8% of revenue.

"Our strong second quarter results demonstrate the meaningful progress we’ve made towards advancing our strategy, helping deliver solid topline results, along with margin and earnings growth," said Carl Hess (NYSE:HES), WTW’s Chief Executive Officer. "I’m pleased with how our businesses continued to prove their value and resilience this quarter."

The Risk & Broking segment led performance with revenue of $1.05 billion, representing 7% growth (6% on an organic basis) from $979 million in the prior year. This segment’s operating margin improved by 60 basis points to 21.2%, driven by strong organic revenue growth and transformation program savings.

Meanwhile, the Health, Wealth & Career segment reported revenue of $1.18 billion, a 6% decrease from the prior year due to the TRANZACT sale, though organic revenue grew 4%. Operating margins in this segment increased 190 basis points to 23.8%.

During the quarter, WTW repurchased 1.6 million shares for $500 million as part of its capital allocation strategy. The company reaffirmed it remains on track to deliver on its financial framework, including mid-single digit organic revenue growth and operating margin expansion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.